Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Celecoxib × 90 days × Clear all

Sponsor

Conditions

Medulloblastoma 3 Rhabdoid Tumor 2 Recurrence 2 Pinealoma 2 Neuroblastoma 2 Ependymoma 2 Solid Tumor 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4 trametinib 2 entrectinib 2 Vemurafenib 2 Specimen Handling 2 Iodine-131 2 tremelimumab 1 selpercatinib 1 omipalisib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 cabozantinib 1 X-Rays 1 Transurethral Resection of Prostate 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Postoperative Period 1 Nivolumab 1 Mitoxantrone 1 Ipilimumab 1 Iodine-124 1 Interviews as Topic 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1 Decision Support Techniques 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡